Use of complementary medicines for osteoarthritis - A prospective study

Annals of the Rheumatic Diseases

Volumn 63, Issue 5, 2004, Pages 549-554

  Zochling, J ^a,b   March, L M ^b   Lapsley, H ^c   Cross, M ^b   Tribe, K ^b   Brooks, P ^c  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; COD LIVER OIL; FISH OIL; GARLIC EXTRACT; GOANNA OIL; OIL; PLANT EXTRACT; PRIMROSE OIL; UNCLASSIFIED DRUG; VITAMIN;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; AUSTRALIA; CELERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; HIP OSTEOARTHRITIS; HUMAN; JOINT PROSTHESIS; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PAIN; PATIENT; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECORDING; SCORING SYSTEM; SEX DIFFERENCE; VITAMIN SUPPLEMENTATION;

AGED; COHORT STUDIES; COMPLEMENTARY THERAPIES; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 1942436197     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.010637     Document Type: Article

References (48)

1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
2. Centers for Disease Control and Prevention. Estimated number of US population with physician-diagnosed osteoarthritis, 1990. Atlanta: Centers for Disease Control and Prevention, 1995.
3. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly: the Framingham osteoarthritis study. Arthritis Rheum 1987;30:914-18.
4. Van Saase JLCM, van Romunde LKJ, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-80.
5. Elders MJ. The increasing impact of arthritis on public health. J Rheumatol 2000;60(suppl):6-8.
6. Mathers C, Penn R. Health system costs of injury, poisoning and musculoskeletal disorders in Australia 1993-4. Canberra: Australian Institute of Health and Welfare, 1999.
7. Ausiello JC, Stafford RS. Trends in medication use for osteoarthritis treatment. J Rheumatol 2002;29:999-1005.
8. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44.
9. March LM, Schwarz JM, Carfrae BH, Bagge E. Clinical validation of self-reported osteoarthritis. Osteoarthritis Cartilage 1998;6:87-93.
10. Bellamy N. WOMAC users guide. London, Ontario: University of Western Ontario, 1995.
11. Ware JE, Brook RH, Davies-Avery A, Williams KN, Stewart AL, Rogers WH, et al. Conceptualization and measurement of health for adults in the health insurance study. Santa Monica: Rand Corporation, 1980.
12. March LM, Cross MJ, Lapsley H, Brnabic AJ, Tribe KL, Bachmeier CJ, et al. Outcomes after hip or knee replacement surgery for osteoarthritis. A prospective cohort study comparing patients' quality of life before and after surgery with age-related population norms. Med J Aust 1999;171:235-8.
13. Bachmeier CJ, March LM, Cross MJ, Lapsley HM, Tribe KL, Courtenay BG, et al. A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. Osteoarthritis Cartilage 2001;9:137-46.
14. March L, Cross M, Tribe K, Lapsley H, Courtenay B, Brooks P. Cost of joint replacement surgery for osteoarthritis: the patients' perspective. J Rheumatol 2002;29:1006-14.
15. Lapsley HM, March LM, Tribe KL, Cross MJ, Brooks PM. Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis Rheum 2001;45:301-6.
16. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996;347:569-73.
17. Ramsey SD, Spencer AC, Topolski TD, Belza B, Patrick DL. Use of alternative therapies by older adults with osteoarthritis. Arthr Care Res 2001;45:222-7.
18. Boisset M, Fitzcharles M-A. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol 1993;21:148-52.
19. Pioro-Boisset M, Esdaile JM, Fitzcharles M-A. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res 1996;9:13-17.
20. Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999;131:409-16.
21. Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001;30:526-31.
22. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, et al. Are the clinical effects of homoeopathy placebo effects? a meta-analysis of placebo-controlled trials. Lancet 1997;350:834-43.
23. McAlindon TE, Jacques P, Zhang X, Hannan MT, Aliabadi P, Weissman B, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39:648-56.
24. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001;44:2531-8.
25. Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt H-H, et al. A randomized, placebo-controlled, cross-over study of ginger extracts and Ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000;8:9-12.
26. Zhang W, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol 1994;46:517-22.
27. Chantre P, Cappelaere A, Leblan D, Guedon D, Vandermander J, Fournie B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of asteoarthritis. Phytomedicine 2000;7:177-83.
28. Lecomte A, Costa JP. Harpagophytum. dans l'arthrose: études en double insu contre placebo. 3702 Le Magazine 1992;15:27-30.
29. Guyader M. Les plantes antirhumatismales. Etude historique et pharmacologique, et étude clinique du nébulisat d'Harpagophytum procumbens DC chez 50 patients arthrosiques suivis en service hospitalier. Paris: Université Pierre et Marie Curie, 1984.
30. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis (Cochrane review). Cochrane Database Syst Rev 2001;3.
31. McAlindan TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75.
32. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 2001;357:251-6.
33. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002;162:2113-23.
34. Bruyere O, Honore A, Ethgen O, Rovati LC, Giacovelli G, Henrontin YE, et al. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage 2003;11:1-5.
35. Leeb BF, Schweitzer H, Montag K, Smolen JS. A meta-analysis of chondroitin sulfate in treatment of osteoarthritis. J Rheumatol 2000;27:205-11.
36. Michel B, Vignon E, de Vathaire F, Frey D, Hauselmann HJ, Stucki G, et al. Oral chondroitin sulphate in knee OA patients: radiographic outcomes of a 2-year prospective study [abstract]. Osteoarthritis Cartilage 2001;9(suppl B):S68.
37. Uebelhart D, Eugene J-M, Thonar A, Delmas PD. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 1998;6(suppl A):S39-46.
38. Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA [abstract]. Osteoarthritis Cartilage 1998;6(suppl A):S37-8.
39. Schmid B, Tschirdewahn B, Kotter I. Analgesic effects of willow bark extract in osteoarthritis: results of a clinical double-blind trial. FACT: Focus Alternative Complementary Ther 1997;3:86.
40. Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001;1:CD002947.
41. Randall C, Randall H, Dobbs F, Hutton C, Sanders H. Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med 2000;93:305-9.
42. Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology (Oxford) 2001;40:779-93.
43. Jacobs JWG, Kraaimaat FW, Bijlsma JWJ. Why do patients with rheumatoid arthritis use alternative treatments. Clin Rheumatol 2001;20:192-6.
44. Buchbinder R, Gingold M, Hall S, Cohen M. Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Intern Med J 2002;32:208-14.
45. Menniti-Ippolito F, Gargiulo L, Bologna E, Forcella E, Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 2002;58:61-4.
46. Cherniack EP, Senzel RS, Pan CX. Correlates of use of alternative medicine by the elderly in an urban population. J Altern Complement Med 2001;7:277-80.
47. Kaboli PJ, Doebbeling BN, Saag KG, Rosenthal GE. Use of complementary and alternative medicine by older patients with arthritis: a population-based study. Arthritis Rheum 2001;45:398-403.
48. Bernstein JH, Shuval JT. Nonconventional medicine in Israel: consultation patterns of the Israeli population and altitudes of primary care physicians. Soc Sci Med 1997;44:1341-8.